seb_ra/iStock via Getty Images
A federal appeals court has ruled that the abortion pill mifepristone can remain on the market, but with certain restrictions.
The decision handed down by the US Fifth Circuit Court of Appeals will remain on hold, however, until the Supreme Court decides to take up the case. If the Supreme Court decides not to hear the case, the appeals court’s restrictions will take effect, according to a CNBC report.
Mifepristone is used with the medication misoprostol to terminate earlier-stage pregnancies. In 2016, the FDA moved to loosen restrictions on the drug, such as allowing it to be dispensed by mail and used into the tenth week of gestation. The drug was first approved by the FDA in 2000.
The drug is distributed in the US by privately held Danco Laboratories, which has been a party to the ongoing litigation.
Dear Readers: We recognize that politics often intersect with the financial news of the day, so we invite you to click here to join the separate political discussion.
More on mifepristone ligitation:
- Supreme Court upholds access to abortion pill mifepristone
- Abortion pill mifepristone legality likely headed to Supreme Court
